Cognivia: Difference between revisions
From Perplex City Wiki
Jump to navigationJump to search
No edit summary |
No edit summary |
||
Line 29: | Line 29: | ||
* Expedin - Accelerates reaction time. | * Expedin - Accelerates reaction time. | ||
* Synergy - Enhances creativity. | * Synergy - Enhances creativity. | ||
* [[Veritana]] - treats [[Barrow-Feld Syndrome]] | |||
==Other Projects== | ==Other Projects== | ||
Line 53: | Line 53: | ||
*Director of Research: [[Dale Robarding]] | *Director of Research: [[Dale Robarding]] | ||
*Spokesman: [[Lawrence Kim]] | |||
==Illicit Connections== | ==Illicit Connections== | ||
Line 66: | Line 66: | ||
*article, 12-JAN-06 "[[Iona Rodie|Iona]] Interviews... [[Dale Robarding]]" ([http://www.perplexcitysentinel.com/archives/2006/01/iona_interviews_13.html link]) | *article, 12-JAN-06 "[[Iona Rodie|Iona]] Interviews... [[Dale Robarding]]" ([http://www.perplexcitysentinel.com/archives/2006/01/iona_interviews_13.html link]) | ||
*article, 23-FEB-06 "Council Ignoring Dangerous Drug Trade" ([http://www.pxcsentinel.com/archives/2006/02/council_ignorin.html link]) | *article, 23-FEB-06 "Council Ignoring Dangerous Drug Trade" ([http://www.pxcsentinel.com/archives/2006/02/council_ignorin.html link]) | ||
*article, 03-MAR-06 "[[Jeanine Lowry-Barton|Mother of Four]] Gains 'Whole New Life' in [[Veritana|Drug Trials]]" ([http://www.perplexcitysentinel.com/archives/2006/04/mother_of_four.html link]) |
Revision as of 19:17, 3 April 2006
Website: http://www.cognivia.com/projects/
General
- Large Consumer Mental Stimulant Manufacturer in Perplex City
- Claims about 68% of all cognitive enhancer sales
- Recently purchased Agilon AI
- Has 4 major offices:
- Corporate Headquarters - 140th to 160th floors of Ascendancy Point
- Cognivia Research - overlooking Polygon Park, near Schrondinger's Junction
- Cognivia North - in Meridian Cross district
- Cognivia Element - in the the West Old Town on New Hampden Street
- Rumours persist that Cognivia even has it's own private subway station.
- That would be at the Cognivia Research division, south of Polygon Park.
- See Lyttleton Station for more on this.
- Engages in live human drug testing (on paid volunteer basis only)
Products
- Ceretin - Broad-spectrum cognitive enhancement.
- Halcyon - Antidepressant and anxiolytic.
- Mnemosyne - Memory and recall booster.
- Cardinal - Enhances analytical and systemising brain function.
- Expedin - Accelerates reaction time.
- Synergy - Enhances creativity.
- Veritana - treats Barrow-Feld Syndrome
Other Projects
- Focal Assisted Transcranial Magnetic Stimulation - Goal: achieve significant improvements in cognitive function in specified areas over a tightly controlled period of time. Project is being conducted with the Academy.
- Cerebral Prostheses - Goal: Encourage the enhancement or restoration of affected cognitive abilities in damaged or poorly functioning areas of the brain.
- Has worked with such patients as Myra Champaign to overcome specific ailments and diseases.
Contacts
- All Customer Enquiries: products at cognivia dot com
- Questions about Ceretin: ceretin at cognivia dot com
- Media information: media at cognivia dot com
Mailing address:
Cognivia Ascendancy Point Perplex City
- Director of Research: Dale Robarding
- Spokesman: Lawrence Kim
Illicit Connections
- Due to the nature of their products, Cognivia often comes under public scrutiny.
- Moreover, their products are often enhanced or altered by illicit drug labs in the city.
- Often, the goal of this sort of drug tailoring is to remove the traces which might be observed by a drug test.
- This is especially useful to participants of the PCAG, who are not allowed to take any enhancements prior to gameplay.
- Although she did not come out and say it, Serena Duncan seemed to insinuate Ryan Cahill may have made his 269 championship win under the influence of such a drug.
References
- article, 12-JAN-06 "Iona Interviews... Dale Robarding" (link)
- article, 23-FEB-06 "Council Ignoring Dangerous Drug Trade" (link)
- article, 03-MAR-06 "Mother of Four Gains 'Whole New Life' in Drug Trials" (link)